Aging Aging

Analysis of Pentosidine 2177. Nagaraj, R. H., Sell, D. R., Prabhakaram, M., Ortwerth, B. J., and Monnier, V. M.(1991) High correlation between pentosidine protein crosslinks and pigmentationimplicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc.Natl. Acad. Sci. USA. 88, 10,257–10,261.8. Odetti, P. O., Fogarty, J., Sell, D. R., and Monnier, V. M. (1992) Chromatographicquantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.Diabetes 41, 153–159.9. Taneda, S. and Monnier, V. M. (1994) ELISA of pentosidine, an advanced glycationend product, in biological specimens. Clin. Chem. 40, 1766–1773.10. Takahashi, M., Kushida, K., Kawana, K., Ishihara, C., Denda, M., Inoue, T., andHoriuchi, K. (1993) Quantification of the cross-link pentosidine in serum fromnormal and uremic subjects. Clin. Chem. 39, 2162–2165.11. Takahashi, M., Ohishi, T., Aoshima, H., Kawana, K., Kushida, K., Inoue, T., andHoriuchi, K. (1993) The Maillard protein cross-link pentosidine in urine from diabeticpatients. Diabetologia 36, 664–667.12. Rodriguez-Garcia, J., Requena, J. R., and Rodriguez-Segade, S. (1998) Increasedconcentrations of serum pentosidine in rheumatoid arthritis. Clin. Chem. 44,250–255.13. Miyata, T., Ishiguro, N., Yasuda, Y., Ito, T., Nangaku, M., Iwata, H., and Kurokawa,K. (1998) Increased pentosidine and advanced glycation end product, in plasmaand synovial fluid from patients with rheumatoid arthritis and its relation with inflammatorymarkers. Biochem. Biophys. Res. Commun. 244, 45–49.14. Dyer, D. G., Blackledge, J. A., Thorpe, S. R., and Baynes, J. W. (1991) Formationof pentosidine during nonenzymatic browning of proteins by glucose. J. Biol. Chem.266, 11,654–11,660.15. Wells-Knecht, K. J., Zyzak, D. V., Litchfield, J. E., Thorpe, S. R., and Baynes, J. W.(1995) Mechanism of autoxidative glycosylation: identification of glyoxal and arabinoseas intermediates in the autoxidative modification of proteins by glucose.Biochemistry 34, 3702–3709.16. Baynes, J. W. (1991) Role of oxidative stress in development of complications indiabetes. Diabetes 40, 405–412.17. McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes,J. W., and Lyons, T. J. (1993) Maillard reaction products and their relation to complicationsin insulin-dependent diabetes mellitus. J. Clin. Invest. 91, 2470–2478.18. Takahashi, M., Suzuki, M., Kushida, K., Miyamoto, S., and Inoue, T. (1997) Relationshipbetween pentosidine levels in serum and urine and activity in rheumatoidarthritis. Br. J. Rheumatol. 36, 637–642.19. Thorpe, S. R. and Baynes, J. W. (1996) Role of the Maillard Reaction in diabetesand diseases of aging. Drugs Aging 9, 69–77.20. Stegemann, H. and Stalder, K. (1967) Determination of hydroxyproline. Clin. Chim.Acta 18, 267–273.